COL11A1 and neoplasm: Although it is mainly involved in the biological process of bone development (18), high levels of COL11A1 are associated with tumor metastasis, treatment resistance, and poor clinical outcome in several solid tumors types such as breast, pancreas, and colorectal cancers (19, 20).